These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28765769)

  • 1. Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center.
    Nishii N; Tachibana M; Morimoto Y; Kawada S; Miyoshi A; Sugiyama H; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H
    J Arrhythm; 2017 Aug; 33(4):338-341. PubMed ID: 28765769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death　- Primary Japanese Experience.
    Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
    Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks Secondary to Cardiac Remodeling: A Unique Case of T Wave Oversensing.
    Saleem M; Pahuja K; Fatima T; Hamilton S; Wjasow C; Fox J
    Cureus; 2022 Jun; 14(6):e26129. PubMed ID: 35875308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcutaneous ICD-current evidence and challenges.
    Patel KH; Lambiase PD
    Cardiovasc Diagn Ther; 2014 Dec; 4(6):449-59. PubMed ID: 25610802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate Shocks With Subcutaneous Implantable Cardioverter-Defibrillator in a Young Patient: A Case Report.
    Khan Z; Sethumadhavan D; Rayner T; Kyaw S
    Cureus; 2023 Feb; 15(2):e34492. PubMed ID: 36874347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation.
    Kiamanesh O; O'Neill D; Sivakumaran S; Kimber S
    HeartRhythm Case Rep; 2015 Jul; 1(4):257-259. PubMed ID: 28491562
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.
    Knops RE; Olde Nordkamp LR; de Groot JR; Wilde AA
    Heart Rhythm; 2013 Aug; 10(8):1240-3. PubMed ID: 23707489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience.
    Al-Ghamdi B; Shafquat A; Alruwaili N; Emmanual S; Shoukri M; Mallawi Y
    Cardiol Res; 2017 Dec; 8(6):319-326. PubMed ID: 29317975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the safety of subcutaneous versus transvenous ICDs: a meta-analysis.
    Su L; Guo J; Hao Y; Tan H
    J Interv Card Electrophysiol; 2021 Apr; 60(3):355-363. PubMed ID: 33432473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Use of the Subcutaneous Implantable Cardioverter Defibrillator and a Permanent Pacemaker.
    Huang J; Patton KK; Prutkin JM
    Pacing Clin Electrophysiol; 2016 Nov; 39(11):1240-1245. PubMed ID: 27734502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
    Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
    Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.
    Sponder M; Khazen C; Dichtl W; Fiedler L; Mörtl D; Teubl A; Steinwender C; Martinek M; Nürnberg M; Dalos D; Kastner J; Schukro C
    Eur J Intern Med; 2018 Feb; 48():64-68. PubMed ID: 28978409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Same-day Discharge after Subcutaneous Implantable Cardioverter-defibrillator Implantation is Safe and Cost-effective.
    Swinning J; Fox K; Billakanty S; Brown S; Chopra N; Fu E; James J; Kidwell G; Kleman J; Murnane V; Nelson S; Nichols A; Nichols SK; Robinson A; Amin A
    J Innov Card Rhythm Manag; 2020 Jun; 11(6):4123-4125. PubMed ID: 32596027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.